Bio News
-
Bio News | Collaborations & Alliances | Industry News
Sherpa Details Added Benefits After PCI Acquisition
Sherpa Clinical Packaging’s President, Mark Paiz, shares the added benefits the acquisition brings PCI's customersOnline Exclusives09.21.18
-
Bio News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Drug Discovery | Facilities | Fill/Finish | Industry News
BeiGene Selects GE’s KUBio
For large-scale production of its cancer monoclonal antibodies (mAbs)Videos
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Abzena Signs Cancer Research Pact with Tmunity Therapeutics
Abzena will humanize monoclonal antibodies using its Composite Human Antibody technology09.20.18
-
Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Drug Development | Industry News
Just Biotherapeutics, Pandion Enter Product Devt. and Mfg. Agreement
Just will apply fully integrated technology platform to speed Pandion's candidates through development and into the clinic09.20.18
-
Analytical Services | Bio News | Bioanalytical Services | Collaborations & Alliances | Industry News | Information Technology
Supply Chain Wizard Selected to Implement OEE Tracker
By an unnamed top-ten Contract Development and Manufacturing Organization09.20.18
-
Bio News | Facilities | Industry News | Process Development
Thermo Fisher to Launch Global Customer Solution Centers
Will provide critical workflows and integrated solutions that help advance chromatography and mass spectrometry worldwide09.20.18
-
Bio News | Bioanalytical Services | Collaborations & Alliances | Industry News
Epicon Begins Operations
The joint venture between Avalon GloboCare Corp and Jiangsu Unicorn Biological Technology Co. occupies a 16,000 sq. ft. space09.20.18
-
Bio News | Biologics, Proteins, Vaccines | Collaborations & Alliances | Industry News | R&D
Oxford Genetics & ERS Genomics Extend Agreement
Their pre-existing non-exclusive, license agreement now includes the use of CRISPR gene editing technology in the APAC region09.20.18
-
Bio News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Propanc, University of Jaén, Spain Enter Collaboration
For the provision of research services and scientific technical advice for the Company's POP1 drug discovery program09.19.18
-
Bio News | Collaborations & Alliances | Industry News
Molecular Templates, Takeda Enter Agreement
For the joint development of CD38-targeted engineered toxin bodies (ETBs) for the treatment of patients with diseases09.19.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
APEIRON & LDC Enter Partnership
To perform drug discovery activities to optimize and develop novel small molecules addressing immune checkpoints09.19.18
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Dyadic, Sanofi in Research Collaboration
To explore the potential of its C1 technology to produce multiple types of biologic vaccines and drugs of interest09.18.18
-
Bio News | Collaborations & Alliances | Industry News
Neurimmune Achieves Milestone in Ono Collaboration
Focused on the development of human-derived antibodies against a novel therapeutic target for neurodegenerative diseases09.18.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Fate & ONO Enter Development Partnership
For the joint development and commercialization of two off-the-shelf CAR-T cell product candidates09.18.18
-
Bio News | Industry News | Promotions & Moves
Metrion Announces Executive Appointments
Dr Edward Stevens joins as head of Drug Discovery, and Dr Andrew Lightfoot as head of Medicinal Chemistry & Discovery Funding09.17.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Evotec, Almirall Sign Research Agreement
To discover and develop first-in-class therapeutics through a novel approach to disrupt cell signalling09.17.18
-
Bio News | Breaking News | Drug Development | Industry News
Allergan to Acquire Bonti for $195M
Adds new neurotoxin programs to medical aesthetics pipeline09.14.18
-
Aseptic Processing | Bio News | Breaking News | Facilities | Industry News
IPS to Provide Engineering Solutions for Althea's New Mfg. Facility
Althea recently expanded operations to include manufacturing of highly potent drug products as well as ADCs09.14.18
-
Bio News | Collaborations & Alliances | Industry News | Regulatory Affairs
Recipharm Receives EMVO Approval
The connection, facilitated by strategic partner TraceLink is to to submit serialization data to the European Hub09.13.18
-
Bio News | Industry News | Promotions & Moves
Particle Sciences Appoints President
Dr. Robert Lee has a decade of service at the company, most recently as executive vice president of Pharmaceutical Services09.13.18
